Abstract
Background: A number of ethical theories have been developed over many centuries, such as deontology, consequentialism (including utilitarianism), virtue ethics, and, more recently, for example, Rawls’ Theory of Justice and Habermas’ Ethics of Discussion, which have been investigated further in healthcare. These major ethical positions and procedural theories integrate many ethical aspects with which decisionmakers, in particular at policy level, are struggling to deliver the best treatments to patients, protect population health, and build sustainable healthcare systems (triple aim). While ethical dilemmas, rooted in this triple aim, are becoming more critical and the demand for accountable processes is rising, multi-criteria decision analysis (MCDA) offers an opportunity to integrate ethical aspects in an innovative manner to enhance accountability for reasonableness (A4R).
Objectives: This chapter is a first attempt to explore how MCDA may integrate ethical aspects inherent to healthcare decisionmaking. The reflection proposed here is primarily rooted in the real-life constraints of decisionmaking at the HTA/Ministry of Health (MoH) level, rather than in specific ethical positions.
Method: This chapter explores the ethical aspects of each MCDA development step, following the eight-step outline of the ISPOR Task Force on MCDA, as well as the legitimacy of decisions from the HTA/MoH perspective, using the triple aim as the goal to illustrate this exploration. For each step, we discuss the substantive and procedural elements of major ethical positions and procedural theories that such method can integrate.
Results: Legitimacy of decisions on healthcare interventions requires inclusion of representative stakeholders for both the design and operationalization of the MCDA to ensure that criteria included and their consideration are in agreement with the mission and values of the institution. Consideration of the triple aim as the goal of the MCDA (step 1) results in the definition of a broad range of criteria (step 2) derived from ethical aspects, such as the “imperative to help” at the patient level, the “prioritization of those who are worst off,” and the aim to achieve the “greatest good for the greatest number” to best serve the population, as well as maintain the sustainability of the healthcare system. The first two MCDA steps foster reflection, collaboration, and communication across stakeholders to define common ground upon which to establish what constitutes the holistic value of interventions, i.e., integrating all ethical aspects of the triple aim. Synthesis of evidence to consider these criteria (step 4) requires elements of practical wisdom to provide clear, transparent, and systematic evidence. Other aspects of MCDA, such as weighting (step 3), scoring (step 5), aggregating of weights and scores (step 6), and managing uncertainty (step 7), include ethical elements of practical wisdom as well as additional procedural values, such as transparency of values, consistency, participation, accountability, and deliberation. The criteria and their consideration through the MCDA process can result in an accountable and reasonable measure of “holistic value” of interventions contributing the most to the triple aim.
Conclusion: This reflection suggests that MCDA can be designed to integrate numerous ethical aspects inherent to healthcare decisionmaking. By enhancing their operationalization, MCDA can support accountable and reasonable decision processes rooted in a holistic consideration of value of healthcare interventions. Reflection on the ethical aspects of MCDA in healthcare is in its infancy, and further research on each aspect presented here is warranted.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Baeroe K, Baltussen R (2014) Legitimate healthcare limit setting in a real-world setting: integrating accountability for reasonableness and multi-criteria decision analysis. Publ Health Ethics 7(2):98–111
Baltussen R, Niessen L (2006) Priority setting of health interventions: the need for multi-criteria decision analysis. Cost Eff Resour Alloc 4:14
Baltussen R, Jansen MP, Mikkelsen E, Tromp N, Hontelez J, Bijlmakers L et al (2016) Priority setting for universal health coverage: we need evidence-informed deliberative processes, not just more evidence on cost-effectiveness. Int J Health Policy Manag 5:615–618
Battista RN, Hodge MJ (2009) The “natural history” of health technology assessment. Int J Technol Assess Health Care 25(Suppl 1):281–284
Beauchamp TL, Childress JF (2001) Principles of biomedical ethics. Oxford University Press, New York
Berwick DM, Nolan TW, Whittington J (2008) The triple aim: care, health, and cost. Health Aff (Millwood) 27(3):759–769
Callahan D (1999) Remembering the goals of medicine. J Eval Clin Pract 5(2):103–106
Centers for Medicare & Medicaid Services (2015) CMS partnership for patients. http://www.ihi.org/topics/cmspartnershipforpatients/Pages/default.aspx. Accessed 26 Nov 2015
Clark S, Weale A (2012) Social values in health priority setting: a conceptual framework. J Health Organ Manag 26(3):293–316
Claxton K, Sculpher M, Palmer S, Culyer AJ (2015) Causes for concern: is NICE failing to uphold its responsibilities to all NHS patients? Health Econ 24(1):1–7
Cleret de Langavant G (2001) La bioéthique Bioéthique: méthode et complexité. Presses de l’Université du Québec, pp 21–52
Daniels N (1999) Decisions about access to health care and accountability for reasonableness. J Urban Health 76(2):176–191
Daniels N (2001) Justice, health, and healthcare. Am J Bioeth 1(2):2–16
Daniels N, Sabin J (1997) Limits to health care: fair procedures, democratic deliberation, and the legitimacy problem for insurers. Philos Public Aff 26(4):303–350
Daniels N, Porteny T, Urritia J (2015) Expanded HTA:enhancing fairness and legitimacy. Int J Health Policy Manag 5(1):1–3
Danis M, Ginsburg M, Goold S (2010) Experience in the United States with public deliberation about health insurance benefits using the small group decision exercise, CHAT. J Ambul Care Manage 33(3):205–214
Dolan JG (2010) Multi-criteria clinical decision support. A primer on the use of multiple-criteria decision-making methods to promote evidence-based, patient-centered healthcare. Patient 3(4):229–248
Driver J (2014 Winter) The history of utilitarianism. In: Zalta EN (ed) The stanford encyclopedia of philosophy. Ed 2014. http://plato.stanford.edu/archives/fall2013/entries/ethics-virtue/
EVIDEM Collaboration (2015) Decision criteria – Conceptual background, definitions, design & instructions. https://www.evidem.org/components-decision.php. Accessed 29 Jul 2015
EVIDEM Collaboration (2015) Evidence and value: impact on DecisionMaking. https://www.evidem.org/. Accessed 17 Sep 2015
Goetghebeur MM, Wagner M, Khoury H, Levitt RJ, Erickson LJ, Rindress D (2008) Evidence and value: impact on DEcisionMaking–the EVIDEM framework and potential applications. BMC Health Serv Res 8:270
Habermas J (1984) The theory of communicative action. Beacon, Boston
Hoedemaekers R, Dekkers W (2003) Justice and solidarity in priority setting in health care. Health Care Anal 11(4):325–343
Hofmann B, Cleemput I, Bond K, Krones T, Droste S, Sacchini D et al (2014a) Revealing and acknowledging value judgments in health technology assessment. Int J Technol Assess Health Care 30(6):579–586
Hofmann B, Droste S, Oortwijn W, Cleemput I, Sacchini D (2014b) Harmonization of ethics in health technology assessment: a revision of the Socratic approach. Int J Technol Assess Health Care 30(1):3–9
Hursthouse R (2013 Fall) Virtue ethics. In: Zalta EN (ed) The stanford encyclopedia of philosophy. Ed 2012. ed.), URL http://plato.stanford.edu/archives/fall2013/entries/ethics-virtue/
Jansen MP, Helderman JK, Boer B, Baltussen R (2016) Fair processes for priority setting: putting theory into practice. Comment on “expanded HTA: enhancing fairness and legitimacy”. Int J Health Policy Manag 5:1–3
Jenicek M (2006) Evidence-based medicine: fifteen years later. Golem the good, the bad, and the ugly in need of a review? Med Sci Monit 12(11):RA241–RA251
Kieslich K (2012) Social values and health priority setting in Germany. J Health Organ Manag 26(3):374–383
Lindemark F, Norheim OF, Johansson KA (2014) Making use of equity sensitive QALYs: a case study on identifying the worse off across diseases. Cost Eff Resour Alloc 12:16
Littlejohns P, Weale A, Chalkidou K, Faden R, Teerawattananon Y (2012) Social values and health policy: a new international research programme. J Health Organ Manag 26(3):285–292
Lown BA (2015) Compassion is a necessity and an individual and collective responsibility comment on “why and how is compassion necessary to provide good quality healthcare?”. Int J Health Policy Manag 4(9):613–614
Martin DK, Abelson J, Singer PA (2002) Participation in health care priority-setting through the eyes of the participants. J Health Serv Res Policy 7(4):222–229
Ottersen T (2013) Lifetime QALY prioritarianism in priority setting. J Med Ethics 39(3):175–180
Peacock SJ, Richardson JR, Carter R, Edwards D (2007) Priority setting in health care using multi-attribute utility theory and programme budgeting and marginal analysis (PBMA). Soc Sci Med 64(4):897–910
Rawls J (1971) A theory of justice. Belknap, Cambridge
Rosenberg-Yunger ZR, Thorsteinsdottir H, Daar AS, Martin DK (2012) Stakeholder involvement in expensive drug recommendation decisions: an international perspective. Health Policy 105(2–3):226–235
Schlander M, Garattini S, Holm S, Kolominsky-Rabas P, Nord E, Persson U et al (2014) Incremental cost per quality-adjusted life year gained? The need for alternative methods to evaluate medical interventions for ultra-rare disorders. J Comp Eff Res 3(4):399–422
Shah KK (2009) Severity of illness and priority setting in healthcare: a review of the literature. Health Policy 93(2–3):77–84
Tanios N, Wagner M, Tony M, Baltussen R, van TJ, Rindress D et al (2013) Which criteria are considered in healthcare decisions? Insights from an international survey of policy and clinical decision makers. Int J Technol Assess Health Care 29(4):456–465
UK Department for Communities and Local Government (2009) Multi-criteria analysis: a manual. London. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/7612/1132618.pdf
Velasco Garrido M, Børlum Kristensen F, Palmhøj Nielsen C, Busse R (2008) Health technology assessment and health policy-making in Europe. Current status, challenges and potential. http://apps.who.int/medicinedocs/en/d/ (Accessed 3 Feb 2016)
Acknowledgment
We wish to acknowledge Bjorn Hofmann (Institute of Health and Society, Center for Medical Ethics, Oslo, Norway) and Ken Bond (CADTH, Ottawa, Ontario, Canada) for their contribution to the development of this chapter, as well as Rob Baltussen (Radboud University, Nijmegen, Netherlands), Ghislaine Cléret de Langavant and Isabelle Ganache (Commissioner for Health and Welfare of the Government of Québec, Montreal, Québec, Canada), Payam Abrishami (ZIN, Netherlands), and Norman Daniels (Harvard School of Public Health, Cambridge, MA, USA) for their insightful advice and review.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Goetghebeur, M., Wagner, M. (2017). Identifying Value(s): A Reflection on the Ethical Aspects of MCDA in Healthcare Decisionmaking. In: Marsh, K., Goetghebeur, M., Thokala, P., Baltussen, R. (eds) Multi-Criteria Decision Analysis to Support Healthcare Decisions. Springer, Cham. https://doi.org/10.1007/978-3-319-47540-0_3
Download citation
DOI: https://doi.org/10.1007/978-3-319-47540-0_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-47538-7
Online ISBN: 978-3-319-47540-0
eBook Packages: MedicineMedicine (R0)